查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1446448

CRM 设备（心律管理设备）市场规模、份额、趋势分析报告：按产品、地区和细分市场预测，2024-2030 年

Cardiac Rhythm Management Devices Market Size, Share & Trends Analysis Report By Products (Pacemakers (Implantable, External), Defibrillators, Cardiac Resynchronization Therapy), By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

CRM设备（心律管理设备）市场成长与趋势：

Grand View Research的最新报告显示，到2030年，全球CRM设备市场规模预计将达到294.6亿美元。

预计 2024 年至 2030 年，该市场将以 6.9% 的复合年增长率扩张。推动市场的主要因素包括由于心血管疾病盛行率的增加而越来越多地采用心律管理（CRM）设备。根据美国疾病管制与预防美国(CDC) 的数据，截至 2021 年 9 月，每年约有 659,000 名美国死于心臟病。在 COVID-19 大流行期间，市场受到了负面影响，因为包括非必要的心血管手术在内的选择性手术被推迟或取消。

美敦Medtronic）、雅培（Abbott）和波士顿科学公司（Boston Scientific Corporation）等市场主要企业的心律管理业务在全球范围内遭受了巨大损失。因此，2020年市场出现负成长。解决心臟麻痹的需求不断成长，导致各类心律管理设备不断创新。植入式设备的创新还包括旨在提高患者舒适度的产品，例如皮下和经静脉设备。瑞典交通局实施了一项试点计划，旨在使用无人机运送 AED。这可以减少 AED 的递送时间并增加及时治疗的生存机会。

因此，由于技术进步和产品创新，市场预计将成长。革命性技术进步的迹象正在迅速改变市场。这种扩张创造了利润丰厚的可能性。领先公司不断增加的研发支出和新产品的推出进一步支持了成长。例如，2020 年 10 月，雅培在印度推出了新的 ICD 和 CRT-D，扩大了在产品系列。该公司还于 2020 年 2 月获得了 Gallant ICD 和 CRT-D 设备的 CE 标誌核准。这些因素正在推动市场成长。主要市场参与者提供广泛的产品，因此在市场上占有重要份额。

CRM 设备市场报告亮点

  • 2023年市场规模为185.7亿美元，预计在预测期内复合年增长率为6.9%。
  • 从产品来看，心臟去颤器由于全球采用率较高，在 2023 年占据市场主导地位，份额超过 39.39%。
  • 在体外心臟去颤器领域，自动体外心臟去颤器领域用于起搏、传送刺激心臟收缩的脉衝电流以及将心律不整和心搏过速转变为正常心率的去心房颤动等应用，其收益占有率最高。因其优点而分享。
  • 2023年，由于心血管疾病盛行率上升以及CRM设备的高普及，北美占据了市场的主导份额。
  • 由于中国和印度等新兴经济体的存在，预计亚太地区在预测期内将呈现良好的成长。

目录

第一章调查方法和范围

第 2 章 CRM 设备市场：执行摘要

  • 市场概述
  • 产品简介
  • 竞争形势概览

第 3 章 CRM 设备市场：变数、趋势与范围

  • 市场区隔和范围
  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
  • 市场驱动因素分析
    • 心血管疾病盛行率增加
    • 对微创手术的偏好增加
  • 市场限制因素分析
    • 与设备相关的高成本
  • CRM设备市场分析工具
    • 产业分析-波特五力分析
    • PESTLE分析
    • 价格分析

第 4 章 CRM 设备：产品估算/趋势分析

  • 2023年及2030年产品市场占有率
  • 细分仪表板
  • 按产品分類的全球 CRM 设备市场展望
  • 2018年至2030年市场规模、预测与趋势分析
    • 心律调节器
    • 心臟去颤器
    • CRT

第五章区域业务分析

  • 2023 年及 2030 年区域市场占有率分析
  • 区域市场仪表板
  • 全球区域市场概述
  • 2018-2030年市场规模及预测趋势分析
  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 西班牙
    • 法国
    • 义大利
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 韩国
    • 泰国
    • 澳洲
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东/非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第六章 竞争形势

  • 主要市场参与企业的最新趋势和影响分析
  • 公司/竞争对手分类
  • 供应商形势
    • Physio-Control, Inc.
    • Medtronic, plc
    • ABBOTT
    • Boston Scientific Corporation
    • Schiller
    • Koninklijke Philips NV
    • Biotronik
    • Progetti Srl
    • Zoll Medical Corporation
    • LivaNova Plc
Product Code: GVR-2-68038-315-7

Cardiac Rhythm Management Devices Market Growth & Trends:

The global cardiac rhythm management devices market size is anticipated to reach USD 29.46 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a lucrative CAGR of 6.9% from 2024 to 2030. The key factors driving the market include growth in the adoption of cardiac rhythm management (CRM) devices owing to the increasing prevalence of cardiovascular disorders. According to the Centers for Disease Control and Prevention (CDC), as of September 2021, approximately 659,000 Americans die suffering from heart disease every year. The market was negatively impacted during the COVID-19 pandemic, as elective procedures, including the non-essential cardiovascular procedures, were postponed or canceled during the pandemic.

Major players in the market such as Medtronic; Abbott; and Boston Scientific Corporation, incurred huge losses in their cardiac rhythm management business segments globally. This resulted in negative growth of the market in 2020. The rising demand for handling sudden cardiac arrests is leading to innovation in all types of cardiac rhythm management devices. Innovation with regards to implantable devices includes products, such as subcutaneous and transvenous devices, that aim to increase the comfort level of patients. Swedish Transport Agency ran a program under the test phase, which aimed to deliver AEDs using a drone. This may reduce the delivery time of an AED, increasing the chances of survival with faster treatment.

Therefore, the market is anticipated to grow because of technological advancements and product innovations. Revolutionary technological signs of progress are rapidly transforming the market. These expansions are producing lucrative potentials. An increase in R&D expenditure and new product launches by leading firms further fueled the growth. For instance, in October 2020, Abbott launched its new ICD and CRT-D in India, hence expanding its product portfolio in the country. The company had also received CE Mark approval for its Gallant ICD and CRT-D devices in February 2020. Such factors boost market growth. Key market players account for a significant share of the market owing to their extensive product offerings.

Cardiac Rhythm Management Devices Market Report Highlights:

  • The market was valued at USD 18.57 billion in 2023 and is expected to expand at a CAGR of 6.9% during the forecast period
  • By product, defibrillators dominated the market with a share of over 39.39% in 2023 due to their high adoption globally
  • In the external defibrillator segment, the automatic external defibrillator segment held the highest revenue share owing to associated benefits, including pacing, i.e., delivering pulses of the current to stimulate heart contraction as well as cardioversion, converting arrhythmia or tachycardia to a normal heartbeat
  • In 2023, North America held the dominant share of the market owing to the rising prevalence of cardiovascular diseases and high adoption of CRM devices
  • Asia Pacific region is expected to show lucrative growth over the forecast period owing to the presence of emerging countries such as China and India

Table of Contents

Chapter 1. Methodology And Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Segment Definitions
      • 1.1.1.1. Product Segment
  • 1.2. Regional Scope
  • 1.3. Estimates And Forecast Timeline
  • 1.4. Objectives
    • 1.4.1. Objective - 1
    • 1.4.2. Objective - 2
  • 1.5. Research Methodology
  • 1.6. Information Procurement
    • 1.6.1. Purchased Database
    • 1.6.2. GVR's Internal Database
    • 1.6.3. Secondary Sources
    • 1.6.4. Primary Research
  • 1.7. Information Or Data Analysis
    • 1.7.1. Data Analysis Models
  • 1.8. Market Formulation & Validation
  • 1.9. Model Details
    • 1.9.1. Commodity Flow Analysis
  • 1.10. List of Primary Sources
  • 1.11. List of Abbreviations

Chapter 2. Cardiac Rhythm Management Devices Market: Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Product Snapshots
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Cardiac Rhythm Management Devices Market Variables, Trends, & Scope

  • 3.1. Market Segmentation And Scope
  • 3.2. Market Lineage Outlook
    • 3.2.1. Parent Market Outlook
    • 3.2.2. Related/Ancillary Market Outlook
  • 3.3. Market Dynamics
  • 3.4. Market Drivers Analysis
    • 3.4.1. Growing prevalence of cardiovascular disease
    • 3.4.2. Increasing preference for minimally invasive procedures
  • 3.5. Market Restraint Analysis
    • 3.5.1. High cost associated with the devices
  • 3.6. Cardiac Rhythm Management Devices Market Analysis Tools
    • 3.6.1. Industry Analysis - Porter's
      • 3.6.1.1. Supplier Power
      • 3.6.1.2. Buyer Power
      • 3.6.1.3. Substitution Threat
      • 3.6.1.4. Threat Of New Entrant
      • 3.6.1.5. Competitive Rivalry
    • 3.6.2. PESTLE Analysis
      • 3.6.2.1. Political Landscape
      • 3.6.2.2. Technological Landscape
      • 3.6.2.3. Economic Landscape
    • 3.6.3. Pricing Analysis

Chapter 4. Cardiac Rhythm Management Devices: Product Estimates & Trend Analysis

  • 4.1. Product Market Share, 2023 & 2030
  • 4.2. Segment Dashboard
  • 4.3. Global Cardiac Rhythm Management Devices Market By Product Outlook
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 To 2030 For the Following
    • 4.4.1. Pacemakers
      • 4.4.1.1. Market Estimates and Forecasts 2018 To 2030 (USD Million)
      • 4.4.1.1.1. Implantable
      • 4.4.1.1.1.1. Market Estimates and Forecasts 2018 To 2030 (USD Million)
      • 4.4.1.1.2. External
      • 4.4.1.1.2.1. Market Estimates and Forecasts 2018 To 2030 (USD Million)
    • 4.4.2. Defibrillators
      • 4.4.2.1. Market Estimates and Forecasts 2018 To 2030 (USD Million)
      • 4.4.2.1.1. Implantable Cardioverter Defibrillators (ICD)
      • 4.4.2.1.1.1. Market Estimates and Forecasts 2018 To 2030 (USD Million)
      • 4.4.2.1.1.1.1. S-ICD
      • 4.4.2.1.1.1.1.1. Market Estimates and Forecasts 2018 To 2030 (USD Million)
      • 4.4.2.1.1.1.2. T-ICD
      • 4.4.2.1.1.1.2.1. Market Estimates and Forecasts 2018 To 2030 (USD Million)
      • 4.4.2.1.2. External Defibrillator
      • 4.4.2.1.2.1. Market Estimates and Forecasts 2018 To 2030 (USD Million)
      • 4.4.2.1.2.1.1. Manual External Defibrillator
      • 4.4.2.1.2.1.1.1. Market Estimates and Forecasts 2018 To 2030 (USD Million)
      • 4.4.2.1.2.1.2. Automatic External Defibrillator
      • 4.4.2.1.2.1.2.1. Market Estimates and Forecasts 2018 To 2030 (USD Million)
      • 4.4.2.1.2.1.3. Wearable Cardioverter Defibrillator
      • 4.4.2.1.2.1.3.1. Market Estimates and Forecasts 2018 To 2030 (USD Million)
    • 4.4.3. Cardiac Resynchronization Therapy (CRT)
      • 4.4.3.1. Market Estimates and Forecasts 2018 To 2030 (USD Million)
      • 4.4.3.1.1. CRT-Defibrillator
      • 4.4.3.1.1.1. Market Estimates and Forecasts 2018 To 2030 (USD Million)
      • 4.4.3.1.2. CRT-Pacemakers
      • 4.4.3.1.2.1. Market Estimates and Forecasts 2018 To 2030 (USD Million)

Chapter 5. Regional Business Analysis

  • 5.1. Regional Market Share Analysis, 2023 & 2030
  • 5.2. Regional Market Dashboard
  • 5.3. Global Regional Market Snapshot
  • 5.4. Marker Size, & Forecasts Trend Analysis, 2018 To 2030:
  • 5.5. North America
    • 5.5.1. U.S.
      • 5.5.1.1. Key Country Dynamics
      • 5.5.1.2. Competitive Scenario
      • 5.5.1.3. Regulatory Framework
      • 5.5.1.4. U.S. Market Estimates and Forecasts 2018 To 2030 (USD Million)
    • 5.5.2. Canada
      • 5.5.2.1. Key Country Dynamics
      • 5.5.2.2. Competitive Scenario
      • 5.5.2.3. Regulatory Framework
      • 5.5.2.4. Canada Market Estimates and Forecasts 2018 To 2030 (USD Million)
  • 5.6. Europe
    • 5.6.1. UK
      • 5.6.1.1. Key Country Dynamics
      • 5.6.1.2. Competitive Scenario
      • 5.6.1.3. Regulatory Framework
      • 5.6.1.4. UK Market Estimates and Forecasts 2018 To 2030 (USD Million)
    • 5.6.2. Germany
      • 5.6.2.1. Key Country Dynamics
      • 5.6.2.2. Competitive Scenario
      • 5.6.2.3. Regulatory Framework
      • 5.6.2.4. Germany Market Estimates and Forecasts 2018 To 2030 (USD Million)
    • 5.6.3. Spain
      • 5.6.3.1. Key Country Dynamics
      • 5.6.3.2. Competitive Scenario
      • 5.6.3.3. Regulatory Framework
      • 5.6.3.4. Spain Market Estimates and Forecasts 2018 To 2030 (USD Million)
    • 5.6.4. France
      • 5.6.4.1. Key Country Dynamics
      • 5.6.4.2. Competitive Scenario
      • 5.6.4.3. Regulatory Framework
      • 5.6.4.4. France Market Estimates and Forecasts 2018 To 2030 (USD Million)
    • 5.6.5. Italy
      • 5.6.5.1. Key Country Dynamics
      • 5.6.5.2. Competitive Scenario
      • 5.6.5.3. Regulatory Framework
      • 5.6.5.4. Italy Market Estimates and Forecasts 2018 To 2030 (USD Million)
    • 5.6.6. Denmark
      • 5.6.6.1. Key Country Dynamics
      • 5.6.6.2. Competitive Scenario
      • 5.6.6.3. Regulatory Framework
      • 5.6.6.4. Denmark Market Estimates and Forecasts 2018 To 2030 (USD Million)
      • 5.6.6.5.
    • 5.6.7. Sweden
      • 5.6.7.1. Key Country Dynamics
      • 5.6.7.2. Competitive Scenario
      • 5.6.7.3. Regulatory Framework
      • 5.6.7.4. Sweden Market Estimates and Forecasts 2018 To 2030 (USD Million)
    • 5.6.8. Norway
      • 5.6.8.1. Key Country Dynamics
      • 5.6.8.2. Competitive Scenario
      • 5.6.8.3. Regulatory Framework
      • 5.6.8.4. Norway Market Estimates and Forecasts 2018 To 2030 (USD Million)
  • 5.7. Asia Pacific
    • 5.7.1. Japan
      • 5.7.1.1. Key Country Dynamics
      • 5.7.1.2. Competitive Scenario
      • 5.7.1.3. Regulatory Framework
      • 5.7.1.4. Japan Market Estimates and Forecasts 2018 To 2030 (USD Million)
    • 5.7.2. China
      • 5.7.2.1. Key Country Dynamics
      • 5.7.2.2. Competitive Scenario
      • 5.7.2.3. Regulatory Framework
      • 5.7.2.4. China Market Estimates and Forecasts 2018 To 2030 (USD Million)
    • 5.7.3. India
      • 5.7.3.1. Key Country Dynamics
      • 5.7.3.2. Competitive Scenario
      • 5.7.3.3. Regulatory Framework
      • 5.7.3.4. India Market Estimates and Forecasts 2018 To 2030 (USD Million)
    • 5.7.4. South Korea
      • 5.7.4.1. Key Country Dynamics
      • 5.7.4.2. Competitive Scenario
      • 5.7.4.3. Regulatory Framework
      • 5.7.4.4. South Korea Market Estimates and Forecasts 2018 To 2030 (USD Million)
    • 5.7.5. Thailand
      • 5.7.5.1. Key Country Dynamics
      • 5.7.5.2. Competitive Scenario
      • 5.7.5.3. Regulatory Framework
      • 5.7.5.4. Thailand Market Estimates and Forecasts 2018 To 2030 (USD Million)
    • 5.7.6. Australia
      • 5.7.6.1. Key Country Dynamics
      • 5.7.6.2. Competitive Scenario
      • 5.7.6.3. Regulatory Framework
      • 5.7.6.4. Australia Market Estimates and Forecasts 2018 To 2030 (USD Million)
  • 5.8. Latin America
    • 5.8.1. Brazil
      • 5.8.1.1. Key Country Dynamics
      • 5.8.1.2. Competitive Scenario
      • 5.8.1.3. Regulatory Framework
      • 5.8.1.4. Brazil Market Estimates and Forecasts 2018 To 2030 (USD Million)
    • 5.8.2. Mexico
      • 5.8.2.1. Key Country Dynamics
      • 5.8.2.2. Competitive Scenario
      • 5.8.2.3. Regulatory Framework
      • 5.8.2.4. Mexico Cardiac Rhythm Management Devices Market, 2018 - 2030 (USD Million)
    • 5.8.3. Argentina
      • 5.8.3.1. Key Country Dynamics
      • 5.8.3.2. Competitive Scenario
      • 5.8.3.3. Regulatory Framework
      • 5.8.3.4. Argentina Market Estimates and Forecasts 2018 To 2030 (USD Million)
  • 5.9. MEA
    • 5.9.1. MEA Cardiac Rhythm Management Devices Market, 2018 - 2030 (USD Million)
    • 5.9.2. South Africa
      • 5.9.2.1. Key Country Dynamics
      • 5.9.2.2. Competitive Scenario
      • 5.9.2.3. Regulatory Framework
      • 5.9.2.4. South Africa Market Estimates and Forecasts 2018 To 2030 (USD Million)
    • 5.9.3. Saudi Arabia
      • 5.9.3.1. Key Country Dynamics
      • 5.9.3.2. Competitive Scenario
      • 5.9.3.3. Regulatory Framework
      • 5.9.3.4. Saudi Arabia Market Estimates and Forecasts 2018 To 2030 (USD Million)
    • 5.9.4. UAE
      • 5.9.4.1. Key Country Dynamics
      • 5.9.4.2. Competitive Scenario
      • 5.9.4.3. Regulatory Framework
      • 5.9.4.4. UAE Market Estimates and Forecasts 2018 To 2030 (USD Million)
    • 5.9.5. Kuwait
      • 5.9.5.1. Key Country Dynamics
      • 5.9.5.2. Competitive Scenario
      • 5.9.5.3. Regulatory Framework
      • 5.9.5.4. Kuwait Market Estimates and Forecasts 2018 To 2030 (USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 6.2. Company /Competition Categorization
  • 6.3. Vendor Landscape
    • 6.3.1. List of Key Distributors And Channel Partners
    • 6.3.2. Key Customers
    • 6.3.3. Key Company Market Share Analysis, 2023
    • 6.3.4. Physio-Control, Inc.
      • 6.3.4.1. Overview
      • 6.3.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 6.3.4.3. Product Benchmarking
      • 6.3.4.4. Strategic Initiatives
    • 6.3.5. Medtronic, plc
      • 6.3.5.1. Overview
      • 6.3.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 6.3.5.3. Product Benchmarking
      • 6.3.5.4. Strategic Initiatives
    • 6.3.6. ABBOTT
      • 6.3.6.1. Overview
      • 6.3.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 6.3.6.3. Product Benchmarking
      • 6.3.6.4. Strategic Initiatives
    • 6.3.7. Boston Scientific Corporation
      • 6.3.7.1. Overview
      • 6.3.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 6.3.7.3. Product Benchmarking
      • 6.3.7.4. Strategic Initiatives
    • 6.3.8. Schiller
      • 6.3.8.1. Overview
      • 6.3.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 6.3.8.3. Product Benchmarking
      • 6.3.8.4. Strategic Initiatives
    • 6.3.9. Koninklijke Philips N.V
      • 6.3.9.1. Overview
      • 6.3.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 6.3.9.3. Product Benchmarking
      • 6.3.9.4. Strategic Initiatives
    • 6.3.10. Biotronik
      • 6.3.10.1. Overview
      • 6.3.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 6.3.10.3. Product Benchmarking
      • 6.3.10.4. Strategic Initiatives
    • 6.3.11. Progetti Srl
      • 6.3.11.1. Overview
      • 6.3.11.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 6.3.11.3. Product Benchmarking
      • 6.3.11.4. Strategic Initiatives
    • 6.3.12. Zoll Medical Corporation
      • 6.3.12.1. Overview
      • 6.3.12.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 6.3.12.3. Product Benchmarking
      • 6.3.12.4. Strategic Initiatives
    • 6.3.13. LivaNova Plc
      • 6.3.13.1. Overview
      • 6.3.13.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 6.3.13.3. Product Benchmarking
      • 6.3.13.4. Strategic Initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America Cardiac Rhythm Management Devices Market, Region, 2018 - 2030 (USD Million)
  • Table 3 North America Cardiac Rhythm Management Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 4 U.S. Cardiac Rhythm Management Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 5 Canada Cardiac Rhythm Management Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 6 Europe Cardiac Rhythm Management Devices Market, Region, 2018 - 2030 (USD Million)
  • Table 7 Europe Cardiac Rhythm Management Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 8 UK Cardiac Rhythm Management Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 9 Germany Cardiac Rhythm Management Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 10 France Cardiac Rhythm Management Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 11 Italy Cardiac Rhythm Management Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 12 Spain Cardiac Rhythm Management Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 13 Sweden Cardiac Rhythm Management Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 14 Norway Cardiac Rhythm Management Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 15 Denmark Cardiac Rhythm Management Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 16 Asia Pacific Cardiac Rhythm Management Devices Market, Region, 2018 - 2030 (USD Million)
  • Table 17 Asia Pacific Cardiac Rhythm Management Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 18 Japan Cardiac Rhythm Management Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 19 China Cardiac Rhythm Management Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 20 India Cardiac Rhythm Management Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 21 Australia Cardiac Rhythm Management Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 22 South Korea Cardiac Rhythm Management Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 23 Thailand Cardiac Rhythm Management Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 24 Latin America Cardiac Rhythm Management Devices Market, Region, 2018 - 2030 (USD Million)
  • Table 25 Latin America Cardiac Rhythm Management Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 26 Brazil Cardiac Rhythm Management Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 27 Mexico Cardiac Rhythm Management Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 28 Argentina Cardiac Rhythm Management Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 29 MEA Cardiac Rhythm Management Devices Market, Region, 2018 - 2030 (USD Million)
  • Table 30 MEA Cardiac Rhythm Management Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 31 South Africa Cardiac Rhythm Management Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 32 Saudi Arabia Cardiac Rhythm Management Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 33 UAE Cardiac Rhythm Management Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 34 Kuwait Cardiac Rhythm Management Devices Market, By Product, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market Research Process
  • Fig. 2 Data Triangulation Techniques
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Primary Interviews in North America
  • Fig. 5 Primary Interviews in Europe
  • Fig. 6 Primary Interviews in APAC
  • Fig. 7 Primary Interviews in Latin America
  • Fig. 8 Primary Interviews in MEA
  • Fig. 9 Market Research Approaches
  • Fig. 10 Value-chain-based Sizing & Forecasting
  • Fig. 11 QFD Modeling for Market Share Assessment
  • Fig. 12 Market Formulation & Validation
  • Fig. 13 Cardiac Rhythm Management Devices Market: Market Outlook
  • Fig. 14 Cardiac Rhythm Management Devices Competitive Insights
  • Fig. 15 Parent Market Outlook
  • Fig. 16 Related/Ancillary Market Outlook
  • Fig. 17 Penetration And Growth Prospect Mapping
  • Fig. 18 Industry Value Chain Analysis
  • Fig. 19 Cardiac Rhythm Management Devices Market Driver Impact
  • Fig. 20 Cardiac Rhythm Management Devices Market Restraint Impact
  • Fig. 21 Cardiac Rhythm Management Devices Market Strategic Initiatives Analysis
  • Fig. 22 Cardiac Rhythm Management Devices Market: Product Movement Analysis
  • Fig. 23 Cardiac Rhythm Management Devices Market: Product Outlook and Key Takeaways
  • Fig. 24 Pacemakers Market Estimates and Forecast, 2018 - 2030
  • Fig. 25 Defibrillators Market Estimates and Forecast, 2018 - 2030
  • Fig. 26 Cardiac Resynchronization Therapy (CRT) Market Estimates and Forecast, 2018 - 2030
  • Fig. 27 Global Cardiac Rhythm Management Devices Market: Regional Movement Analysis
  • Fig. 28 Global Cardiac Rhythm Management Devices Market: Regional Outlook and Key Takeaways
  • Fig. 29 Global Cardiac Rhythm Management Devices Market Share and Leading Players
  • Fig. 30 North America Market Share and Leading Players
  • Fig. 31 Europe Market Share and Leading Players
  • Fig. 32 Asia Pacific Market Share and Leading Players
  • Fig. 33 Latin America Market Share and Leading Players
  • Fig. 34 Middle East & Africa Market Share and Leading Players
  • Fig. 35 North America, By Country
  • Fig. 36 North America
  • Fig. 37 North America Market Estimates and Forecasts, 2018 - 2030
  • Fig. 38 U.S.
  • Fig. 39 U.S. Market Estimates and Forecasts, 2018 - 2030
  • Fig. 40 Canada
  • Fig. 41 Canada Market Estimates and Forecasts, 2018 - 2030
  • Fig. 42 Europe
  • Fig. 43 Europe Market Estimates and Forecasts, 2018 - 2030
  • Fig. 44 UK
  • Fig. 45 UK Market Estimates and Forecasts, 2018 - 2030
  • Fig. 46 Germany
  • Fig. 47 Germany Market Estimates and Forecasts, 2018 - 2030
  • Fig. 48 France
  • Fig. 49 France Market Estimates and Forecasts, 2018 - 2030
  • Fig. 50 Italy
  • Fig. 51 Italy Market Estimates and Forecasts, 2018 - 2030
  • Fig. 52 Spain
  • Fig. 53 Spain Market Estimates and Forecasts, 2018 - 2030
  • Fig. 54 Denmark
  • Fig. 55 Denmark Market Estimates and Forecasts, 2018 - 2030
  • Fig. 56 Sweden
  • Fig. 57 Sweden Market Estimates and Forecasts, 2018 - 2030
  • Fig. 58 Norway
  • Fig. 59 Norway Market Estimates and Forecasts, 2018 - 2030
  • Fig. 60 Asia Pacific
  • Fig. 61 Asia Pacific Market Estimates and Forecasts, 2018 - 2030
  • Fig. 62 China
  • Fig. 63 China Market Estimates and Forecasts, 2018 - 2030
  • Fig. 64 Japan
  • Fig. 65 Japan Market Estimates and Forecasts, 2018 - 2030
  • Fig. 66 India
  • Fig. 67 India Market Estimates and Forecasts, 2018 - 2030
  • Fig. 68 Thailand
  • Fig. 69 Thailand Market Estimates and Forecasts, 2018 - 2030
  • Fig. 70 South Korea
  • Fig. 71 South Korea Market Estimates and Forecasts, 2018 - 2030
  • Fig. 72 Australia
  • Fig. 73 Australia Market Estimates and Forecasts, 2018 - 2030
  • Fig. 74 Latin America
  • Fig. 75 Latin America Market Estimates and Forecasts, 2018 - 2030
  • Fig. 76 Brazil
  • Fig. 77 Brazil Market Estimates and Forecasts, 2018 - 2030
  • Fig. 78 Mexico
  • Fig. 79 Mexico Market Estimates and Forecasts, 2018 - 2030
  • Fig. 80 Argentina
  • Fig. 81 Argentina Market Estimates and Forecasts, 2018 - 2030
  • Fig. 82 Middle East and Africa
  • Fig. 83 Middle East and Africa Market Estimates and Forecasts, 2018 - 2030
  • Fig. 84 South Africa
  • Fig. 85 South Africa Market Estimates and Forecasts, 2018 - 2030
  • Fig. 86 Saudi Arabia
  • Fig. 87 Saudi Arabia Market Estimates and Forecasts, 2018 - 2030
  • Fig. 88 UAE
  • Fig. 89 UAE Market Estimates and Forecasts, 2018 - 2030
  • Fig. 90 Kuwait
  • Fig. 91 Kuwait Market Estimates and Forecasts, 2018 - 2030
  • Fig. 92 Market Share of Key Market Players- Cardiac Rhythm Management Devices Market